Metraipolis › archive › dc_92424ec2b2cb
Arvanil reverses cisplatin resistance in ovarian cancer by activating HMOX1-driven ferroptosis — Europe PMC PMID:42069794
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42069794
- DOI
- 10.1038/s41598-[numero omesso]-4
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T19:35:56.279Z
- SHA-256 of the archived text
839689f9957dad42311f0062cf75427d63803f31ba3cc7ae6ce6278dba0cca56- Stable URL of this page
https://metraipolis.com/documento/dc_92424ec2b2cb
How to cite
Arvanil reverses cisplatin resistance in ovarian cancer by activating HMOX1-driven ferroptosis — Europe PMC PMID:42069794 — Europe PMC (en), https://europepmc.org/article/MED/42069794 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_92424ec2b2cb (Metraipolis archive dc_92424ec2b2cb, sha256 839689f9957dad42311f0062cf75427d63803f31ba3cc7ae6ce6278dba0cca56)
BibTeX
@misc{dc92424ec2b2cb,
title = {Arvanil reverses cisplatin resistance in ovarian cancer by activating HMOX1-driven ferroptosis — Europe PMC PMID:42069794},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42069794},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_92424ec2b2cb; sha256 839689f9957dad42311f0062cf75427d63803f31ba3cc7ae6ce6278dba0cca56},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42069794. Agents can read the archived copy with the MCP tool read_document.